Related Experiment Video

Updated: Mar 7, 2026

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice
07:44

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice

Published on: February 17, 2023

2.2K

Rap1GAP inhibits tumor progression in endometrial cancer

Masato Tamate1, Ryoichi Tanaka1, Hiroyuki Osogami1

  • 1Department of Obstetrics and Gynecology, Sapporo Medical University Hospital, South1 West16, Chuo-ku, Sapporo, Hokkaido, Japan.

Biochemical and Biophysical Research Communications
|February 16, 2017
PubMed
Abstract

Insights

Rap1GAP acts as a tumor suppressor in endometrioid adenocarcinoma (EAC), inhibiting cancer cell migration and invasion. Low Rap1GAP expression correlates with poor EAC differentiation and predicts worse survival, highlighting its prognostic value.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Endometrioid adenocarcinoma (EAC) incidence is rising.
  • Rap1GAP is a known tumor suppressor in other cancers, but its role in EAC is unstudied.

Purpose of the Study:

  • To investigate the tumor-suppressing role of Rap1GAP in EAC.
  • To determine the prognostic significance of Rap1GAP expression in EAC patients.

Main Methods:

  • Real-time RT-PCR and western blotting assessed Rap1GAP levels in EAC cell lines.
  • Immunohistochemical staining for Rap1GAP and E-cadherin was performed on 114 EAC patient tumors.
  • Cox regression analysis evaluated prognostic variables.

Main Results:

  • Low Rap1GAP expression was found in poorly differentiated EAC cells.
  • Rap1GAP deficiency enhanced cancer cell migration and invasion.
  • Higher Rap1GAP and E-cadherin levels correlated with improved overall survival and were independent prognostic factors.

Conclusions:

  • Rap1GAP functions as a tumor suppressor in EAC by inhibiting cell migration and invasion.
  • Low Rap1GAP expression is linked to poor differentiation and serves as a significant prognostic marker in EAC.
Keywords:
E-cadherinEndometrial carcinomaEndometrioid adenocarcinomaRap1GAPTumor suppressor

More Related Videos

The Use of Mouse Mammary Tumor Cells in an In Vitro Invasion Assay as a Measure of Oncogenic Cell Behavior08:12

The Use of Mouse Mammary Tumor Cells in an In Vitro Invasion Assay as a Measure of Oncogenic Cell Behavior

Published on: June 12, 2019

5.5K
An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

8.7K

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K